investorscraft@gmail.com

Intrinsic Value of Codiak BioSciences, Inc. (CDAK)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-09-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %686.8NaN
Revenue, $23NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m92NaN
Operating income, $m-70NaN
EBITDA, $m-64NaN
Interest expense (income), $mNaN
Earnings before tax, $m6NaN
Tax expense, $m43NaN
Net income, $m-37NaN

BALANCE SHEET

Cash and short-term investments, $m77NaN
Total assets, $m172NaN
Adjusted assets (=assets-cash), $m95NaN
Average production assets, $m150NaN
Working capital, $m63NaN
Total debt, $m28NaN
Total liabilities, $m118NaN
Total equity, $m54NaN
Debt-to-equity ratio0.525NaN
Adjusted equity ratio-0.219NaN

CASH FLOW

Net income, $m-37NaN
Depreciation, amort., depletion, $m5NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-74NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-3NaN
Free cash flow, $m-71NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m63
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount